NCT02989467View on ClinicalTrials.gov

Effects of Aprepitant on Satiation, Gastric Volume, Gastric Accommodation and Gastric Emptying

PHASE1CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

January 27, 2017

Primary Completion Date

November 20, 2017

Study Completion Date

January 1, 2018

Conditions
Healthy
Interventions
DRUG

Aprepitant

Subjects will receive one tablet daily for 5 consecutive days. On Day 1 subjects will take a 125mg tablet, on Days 2-5, subjects will take an 80 mg tablet.

DRUG

Placebo

Subjects will receive one placebo tablet daily for 5 consecutive days.

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER